Evidence map›Paper›PMID 39085906›Full record

ArticleBMC pulmonary medicine2024

Impact of pneumothorax on mortality, morbidity, and hospital resource utilization in COVID-19 patients: a propensity matched analysis of nationwide inpatient sample database.

Adeel Nasrullah, Mohammed A Quazi, Shiza Virk, Sitara Niranjan, Muhammad Ali Butt, Muhammad Hassan Shakir, Amir Humza Sohail, Muhammad Ibraiz Bilal, Taimur Muzammil, Briana DiSilvio and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC pulmonary medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Pneumothorax: Demographics, Treatment, and Nursing Care.Healthcare (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Adeel NasrullahDivision of Pulmonary and Critical Care, Allegheny Health Network, Pittsburgh, PA, 15212, USA. adeel.nasrullah@ahn.org.
Mohammed A QuaziDepartment of Psychiatry and Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque, NM, 87131, USA.
Shiza VirkDepartment of Internal Medicine, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Sitara NiranjanDepartment of Internal Medicine, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Muhammad Ali ButtDepartment of Internal Medicine, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Muhammad Hassan ShakirDepartment of Internal Medicine, The Wright Center for Graduate Medical Education, Scranton, PA, 18505, USA.
Amir Humza SohailDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, 87131, USA.
Muhammad Ibraiz BilalDepartment of Internal Medicine, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Taimur MuzammilDepartment of Internal Medicine, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Briana DiSilvioDivision of Pulmonary and Critical Care, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Abu Baker SheikhDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, 87131, USA.
Tariq CheemaDivision of Pulmonary and Critical Care, Allegheny Health Network, Pittsburgh, PA, 15212, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpontaneous pneumothorax (PTX) is more prevalent among COVID-19 patients than other critically ill patients, but studies on this are limited. This study compared clinical characteristics and in-hospital outcomes among COVID-19 patients with concomitant PTX to provide insight into how PTX affects health care utilization and complications, which informs clinical decisions and healthcare resource allocation.

methodsThe 2020 Nationwide Inpatient Sample was used analyze patient demographics and outcomes, including age, race, sex, insurance status, median income, length of hospital stay, mortality rate, hospitalization costs, comorbidities, mechanical ventilation, and vasopressor support. Propensity score matching was employed for additional analysis.

resultsAmong 1,572,815 COVID-19 patients, 1.41% had PTX. These patients incurred significantly higher hospitalization costs ($435,508 vs. $96,668, p < 0.001) and longer stays (23.6 days vs. 8.6 days, p < 0.001). In-hospital mortality was substantially elevated for PTX patients (65.8% vs. 14.4%, p < 0.001), with an adjusted odds ratio of 14.3 (95% CI 12.7-16.2). Additionally, these patients were more likely to require vasopressors (16.6% vs. 3.3%), mechanical circulatory support (3.5% vs. 0.3%), hemodialysis (16.6% vs. 5.6%), invasive mechanical ventilation (76.9% vs. 15.1%), non-invasive mechanical ventilation (19.1% vs. 5.8%), tracheostomy (13.3% vs. 1.1%), and chest tube placement (59.8% vs. 0.8%).

conclusionsOur findings highlight the severe impact of PTX on COVID-19 patients, characterized by higher mortality, more complications, and increased resource utilization. Also, being Hispanic, male, or obese increased the risk of developing concomitant PTX with COVID-19.

Indexed as

COVID-19Hospital MortalityPneumothoraxPropensity ScoreAdultAgedComorbidityDatabases, FactualFemaleHospitalizationHumansLength of StayMaleMiddle AgedPatient Acceptance of Health CareRespiration, ArtificialComplicationsCOVID-19MortalityNational inpatient samplePneumothoraxPrevalenceSARS-CoV-2

Identifiers

PMID39085906
PMCPMC11293109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.